Phenovista Appoints Ellen Berg, PhD, an Expert in the Mechanisms of Drug and Disease Biology and Cell-Based Assays, to its Scientific Advisory Board
Dr. Berg is the Founder of Alto Predict and is an expert in human cell-based in vitro assays and platforms for drug discovery and chemical safety applications.
- Dr. Berg is the Founder of Alto Predict and is an expert in human cell-based in vitro assays and platforms for drug discovery and chemical safety applications.
- “We are thrilled to announce that Ellen is joining our Scientific Advisory Board,” said James Evans, PhD, Chief Executive Officer of Phenovista.
- She has a background in biopharmaceutical research and drug discovery contract research services with startup, operations, and commercialization experience.
- Her research interests include mechanisms of human disease biology and drug action, predictive toxicology, and research information science, including AI/ML approaches and data visualization.